Nurix Therapeutics, Inc. NRIX
NASDAQ
| 08/31/2026 | 05/31/2026 | 02/28/2026 | 11/30/2025 | 08/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.05B | 443.53M | 540.73M | 592.94M | 428.83M |
| Total Receivables | 22.80M | 1.90M | 2.40M | 1.50M | 1.70M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 32.64M | 11.05M | 11.26M | 12.38M | 10.07M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 1.10B | 456.48M | 554.39M | 606.82M | 440.60M |
|
|
|||||
| Total Current Assets | 1.10B | 456.48M | 554.39M | 606.82M | 440.60M |
| Net Property, Plant & Equipment | 68.04M | 70.11M | 73.35M | 73.01M | 73.53M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 8.74M | 8.95M | 8.38M | 8.31M | 8.34M |
| Total Assets | 1.20B | 535.54M | 636.13M | 688.14M | 522.47M |
|
|
|||||
| Total Accounts Payable | 32.98M | 12.21M | 10.29M | 11.22M | 8.61M |
| Total Accrued Expenses | 48.24M | 41.72M | 56.99M | 51.70M | 41.30M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.24M | 3.22M | 3.20M | 2.82M | 3.79M |
| Total Finance Division Other Current Liabilities | 46.27M | 14.88M | 21.72M | 20.74M | 28.66M |
| Total Other Current Liabilities | 46.27M | 14.88M | 21.72M | 20.74M | 28.66M |
| Total Current Liabilities | 130.74M | 72.02M | 92.20M | 86.47M | 82.35M |
|
|
|||||
| Total Current Liabilities | 130.74M | 72.02M | 92.20M | 86.47M | 82.35M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 62.09M | 54.92M | 55.45M | 52.91M | 52.70M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 34.15M | 5.97M | 7.59M | 10.01M | 15.18M |
| Total Liabilities | 226.99M | 132.91M | 155.24M | 149.39M | 150.22M |
|
|
|||||
| Common Stock & APIC | 1.60B | 1.58B | 1.57B | 1.54B | 1.30B |
| Retained Earnings | -630.13M | -1.18B | -1.09B | -1.00B | -925.01M |
| Treasury Stock & Other | -210.00K | -145.00K | 56.00K | 105.00K | 119.00K |
| Total Common Equity | 968.31M | 402.63M | 480.89M | 538.75M | 372.25M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 968.31M | 402.63M | 480.89M | 538.75M | 372.25M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 968.31M | 402.63M | 480.89M | 538.75M | 372.25M |
|
|
|||||